
Titan Biotech Ltd Technical Momentum Shifts Amid Mixed Indicator Signals
2026-05-20 08:03:35Titan Biotech Ltd, a micro-cap player in the Specialty Chemicals sector, has experienced a notable shift in its technical momentum, reflecting a nuanced market sentiment. Despite a recent downgrade from a Buy to a Hold rating by MarketsMOJO, the stock’s long-term returns remain impressive, though short-term price action signals caution.
Read MoreBoard Meeting Intimation for Consideration And Approval Of Standalone And Consolidated Unaudited Financial Results For The Quarter Ended June 30 2026.
05-Aug-2026 | Source : BSETitan Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve the standalone and consolidated unaudited financial results for the quarter ended June 30 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
06-Jul-2026 | Source : BSECompliance certificate under Reg. 74(5) of SEBI (DP) Regulations 2018
Closure of Trading Window
23-Jun-2026 | Source : BSEClosure of trading window
Corporate Actions
13 Aug 2026
Titan Biotech Ltd has declared 20% dividend, ex-date: 19 Sep 25
Titan Biotech Ltd has announced 2:10 stock split, ex-date: 20 Feb 26
No Bonus history available
No Rights history available